Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrition ; 96: 111570, 2022 04.
Article in English | MEDLINE | ID: mdl-35063810

ABSTRACT

OBJECTIVES: Muscle wasting is a common complication in patients with nonalcoholic fatty liver disease (NAFLD). In this study, we investigated the effect of NAFLD on satellite cell (SC) content and skeletal muscle repair. METHODS: Male CD-1 mice fed a choline-deficient diet for 4 wk were used as an NAFLD model. We performed histologic and mRNA expression analyses, immunochemical staining with single muscle fibers to assess the effect of NAFLD on muscle Pax7+ SCs, and muscle regeneration by intramuscular injection of cardiotoxin. RESULTS: We found that the total number of Pax7+ SCs in the extensor digitorum longus and tibialis anterior muscles of mice with NAFLD was significantly decreased when compared with that in the control group, in which the depletion of the SC pool possibly impaired muscle regeneration, as evidenced by the smaller size of the regenerating myofibers. Importantly, we found that NAFLD significantly impaired the differentiation ability of SCs, as shown by a decreased number of SCs expressing a myogenic marker, MyoD. Finally, this study indicated that molecular mechanisms underlying a decline in SC numbers may be attributed to the upregulation of proinflammatory cytokines (tumor necrosis factor α [TNFα]) and an oxidative stress marker (NADPH oxidase-2 [NOX2\) in mice with NAFLD. CONCLUSIONS: The findings demonstrate that a decrease in SC content in the skeletal muscle is an important factor that contributes to muscle wasting in NAFLD. Thus, preservation of the muscle SC pool is a potential therapeutic strategy to reduce NAFLD-associated muscle wasting.


Subject(s)
Non-alcoholic Fatty Liver Disease , Satellite Cells, Skeletal Muscle , Animals , Cell Differentiation , Disease Models, Animal , Humans , Male , Mice , Muscle Development , Muscle, Skeletal/metabolism , Muscular Atrophy/pathology , Non-alcoholic Fatty Liver Disease/metabolism , Satellite Cells, Skeletal Muscle/metabolism , Satellite Cells, Skeletal Muscle/pathology
2.
Life Sci ; 184: 103-111, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28711489

ABSTRACT

AIMS: Choline-deficient diet is extensively used as a model of nonalcoholic fatty liver disease (NAFLD). In this study, we explored genes in the liver for which the expression changed in response to the choline-deficient (CD) diet. MAIN METHODS: Male CD-1 mice were divided into two groups and fed a CD diet with or without 0.2% choline bitartrate for one or three weeks. Hepatic levels of choline metabolites were analyzed by using liquid chromatography mass spectrometry and hepatic gene expression profiles were examined by DNA microarray analysis. KEY FINDINGS: The CD diet lowered liver choline metabolites after one week and exacerbated fatty liver between one and three weeks. We identified >300 genes whose expression was significantly altered in the livers of mice after consumption of this CD diet for one week and showed that liver gene expression profiles could be classified into six distinct groups. This study showed that STAT1 and interferon-regulated genes was up-regulated after the CD diet consumption and that the Stat1 mRNA level was negatively correlated with liver phosphatidylcholine level. Stat1 mRNA expression was actually up-regulated in isolated hepatocytes from the mouse liver with the CD diet. SIGNIFICANCE: This study provides insight into the genomic effects of the CD diet through the Stat1 expression, which might be involved in NAFLD development.


Subject(s)
Choline/metabolism , Gene Expression Profiling , Hepatocytes/metabolism , Liver/physiopathology , Non-alcoholic Fatty Liver Disease/physiopathology , Animals , Choline Deficiency/complications , Chromatography, Liquid , Disease Models, Animal , Liver/metabolism , Male , Mass Spectrometry , Mice , Mice, Inbred ICR , Non-alcoholic Fatty Liver Disease/genetics , Oligonucleotide Array Sequence Analysis , Phosphatidylcholines/metabolism , RNA, Messenger , STAT1 Transcription Factor/genetics , Time Factors , Transcriptome
SELECTION OF CITATIONS
SEARCH DETAIL